Logo image of QS51.DE

STRAUMANN HOLDING AG-REG (QS51.DE) Stock Fundamental Analysis

FRA:QS51 - Deutsche Boerse Ag - CH1175448666 - Common Stock - Currency: EUR

114.7  -1.8 (-1.55%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to QS51. QS51 was compared to 58 industry peers in the Health Care Equipment & Supplies industry. QS51 scores excellent points on both the profitability and health parts. This is a solid base for a good stock. QS51 is quite expensive at the moment. It does show a decent growth rate. With these ratings, QS51 could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year QS51 was profitable.
QS51 had a positive operating cash flow in the past year.
Each year in the past 5 years QS51 has been profitable.
In the past 5 years QS51 always reported a positive cash flow from operatings.
QS51.DE Yearly Net Income VS EBIT VS OCF VS FCFQS51.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

QS51 has a better Return On Assets (10.73%) than 87.93% of its industry peers.
QS51 has a better Return On Equity (19.03%) than 84.48% of its industry peers.
QS51 has a Return On Invested Capital of 19.95%. This is amongst the best in the industry. QS51 outperforms 98.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QS51 is significantly above the industry average of 8.41%.
The last Return On Invested Capital (19.95%) for QS51 is above the 3 year average (19.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.73%
ROE 19.03%
ROIC 19.95%
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
QS51.DE Yearly ROA, ROE, ROICQS51.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of QS51 (15.51%) is better than 84.48% of its industry peers.
In the last couple of years the Profit Margin of QS51 has declined.
QS51 has a Operating Margin of 25.97%. This is amongst the best in the industry. QS51 outperforms 94.83% of its industry peers.
QS51's Operating Margin has been stable in the last couple of years.
The Gross Margin of QS51 (71.40%) is better than 77.59% of its industry peers.
In the last couple of years the Gross Margin of QS51 has remained more or less at the same level.
Industry RankSector Rank
OM 25.97%
PM (TTM) 15.51%
GM 71.4%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
QS51.DE Yearly Profit, Operating, Gross MarginsQS51.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), QS51 is creating value.
Compared to 1 year ago, QS51 has about the same amount of shares outstanding.
The number of shares outstanding for QS51 has been increased compared to 5 years ago.
Compared to 1 year ago, QS51 has an improved debt to assets ratio.
QS51.DE Yearly Shares OutstandingQS51.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
QS51.DE Yearly Total Debt VS Total AssetsQS51.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

QS51 has an Altman-Z score of 8.99. This indicates that QS51 is financially healthy and has little risk of bankruptcy at the moment.
QS51 has a better Altman-Z score (8.99) than 96.55% of its industry peers.
The Debt to FCF ratio of QS51 is 1.49, which is an excellent value as it means it would take QS51, only 1.49 years of fcf income to pay off all of its debts.
QS51 has a Debt to FCF ratio of 1.49. This is amongst the best in the industry. QS51 outperforms 93.10% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that QS51 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.11, QS51 belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.49
Altman-Z 8.99
ROIC/WACC4.05
WACC4.92%
QS51.DE Yearly LT Debt VS Equity VS FCFQS51.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.61 indicates that QS51 should not have too much problems paying its short term obligations.
QS51 has a Current ratio (1.61) which is comparable to the rest of the industry.
A Quick Ratio of 1.15 indicates that QS51 should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.15, QS51 perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
The current and quick ratio evaluation for QS51 is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.15
QS51.DE Yearly Current Assets VS Current LiabilitesQS51.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

QS51 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.72%.
Measured over the past 5 years, QS51 shows a small growth in Earnings Per Share. The EPS has been growing by 5.26% on average per year.
The Revenue has grown by 9.98% in the past year. This is quite good.
QS51 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.42% yearly.
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%

3.2 Future

The Earnings Per Share is expected to grow by 19.31% on average over the next years. This is quite good.
QS51 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
QS51.DE Yearly Revenue VS EstimatesQS51.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
QS51.DE Yearly EPS VS EstimatesQS51.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

QS51 is valuated quite expensively with a Price/Earnings ratio of 39.15.
Compared to the rest of the industry, the Price/Earnings ratio of QS51 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.17. QS51 is valued slightly more expensive when compared to this.
QS51 is valuated quite expensively with a Price/Forward Earnings ratio of 29.77.
QS51's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of QS51 to the average of the S&P500 Index (22.10), we can say QS51 is valued slightly more expensively.
Industry RankSector Rank
PE 39.15
Fwd PE 29.77
QS51.DE Price Earnings VS Forward Price EarningsQS51.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QS51 is on the same level as its industry peers.
QS51's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.26
EV/EBITDA 21.43
QS51.DE Per share dataQS51.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
QS51 has an outstanding profitability rating, which may justify a higher PE ratio.
QS51's earnings are expected to grow with 19.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.24
PEG (5Y)7.44
EPS Next 2Y22.85%
EPS Next 3Y19.99%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.87%, QS51 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.19, QS51 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, QS51's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

On average, the dividend of QS51 grows each year by 10.12%, which is quite nice.
Dividend Growth(5Y)10.12%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

QS51 pays out 34.88% of its income as dividend. This is a sustainable payout ratio.
QS51's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.88%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
QS51.DE Yearly Income VS Free CF VS DividendQS51.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
QS51.DE Dividend Payout.QS51.DE Dividend Payout, showing the Payout Ratio.QS51.DE Dividend Payout.PayoutRetained Earnings

STRAUMANN HOLDING AG-REG

FRA:QS51 (5/28/2025, 7:00:00 PM)

114.7

-1.8 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30
Earnings (Next)08-13 2025-08-13
Inst Owners37.88%
Inst Owner ChangeN/A
Ins Owners32.73%
Ins Owner ChangeN/A
Market Cap18.29B
Analysts73.57
Price Target143.67 (25.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.91
Dividend Growth(5Y)10.12%
DP34.88%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 39.15
Fwd PE 29.77
P/S 6.84
P/FCF 54.26
P/OCF 35.43
P/B 8.39
P/tB 15.07
EV/EBITDA 21.43
EPS(TTM)2.93
EY2.55%
EPS(NY)3.85
Fwd EY3.36%
FCF(TTM)2.11
FCFY1.84%
OCF(TTM)3.24
OCFY2.82%
SpS16.77
BVpS13.66
TBVpS7.61
PEG (NY)1.24
PEG (5Y)7.44
Profitability
Industry RankSector Rank
ROA 10.73%
ROE 19.03%
ROCE 24.3%
ROIC 19.95%
ROICexc 24.14%
ROICexgc 40.83%
OM 25.97%
PM (TTM) 15.51%
GM 71.4%
FCFM 12.61%
ROA(3y)10.34%
ROA(5y)9.59%
ROE(3y)18.64%
ROE(5y)18%
ROIC(3y)19.58%
ROIC(5y)17.81%
ROICexc(3y)24.47%
ROICexc(5y)23.84%
ROICexgc(3y)42.44%
ROICexgc(5y)41.27%
ROCE(3y)23.86%
ROCE(5y)21.7%
ROICexcg growth 3Y-8.65%
ROICexcg growth 5Y-1.8%
ROICexc growth 3Y-7.31%
ROICexc growth 5Y1.25%
OM growth 3Y-1.01%
OM growth 5Y0.13%
PM growth 3Y-7.49%
PM growth 5Y-4.18%
GM growth 3Y-2.13%
GM growth 5Y-1.1%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.49
Debt/EBITDA 0.29
Cap/Depr 115.76%
Cap/Sales 6.7%
Interest Coverage 43.15
Cash Conversion 60.78%
Profit Quality 81.28%
Current Ratio 1.61
Quick Ratio 1.15
Altman-Z 8.99
F-Score7
WACC4.92%
ROIC/WACC4.05
Cap/Depr(3y)127.11%
Cap/Depr(5y)116.21%
Cap/Sales(3y)7.81%
Cap/Sales(5y)7.04%
Profit Quality(3y)86.54%
Profit Quality(5y)138.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.72%
EPS 3Y-1.14%
EPS 5Y5.26%
EPS Q2Q%-26.32%
EPS Next Y31.67%
EPS Next 2Y22.85%
EPS Next 3Y19.99%
EPS Next 5Y19.31%
Revenue 1Y (TTM)9.98%
Revenue growth 3Y7.39%
Revenue growth 5Y9.42%
Sales Q2Q%8.65%
Revenue Next Year8.48%
Revenue Next 2Y9.47%
Revenue Next 3Y9.7%
Revenue Next 5Y9.77%
EBIT growth 1Y3.25%
EBIT growth 3Y6.31%
EBIT growth 5Y9.56%
EBIT Next Year31.64%
EBIT Next 3Y18.52%
EBIT Next 5Y16.77%
FCF growth 1Y0.35%
FCF growth 3Y-10.44%
FCF growth 5Y6.66%
OCF growth 1Y-4.08%
OCF growth 3Y-4.8%
OCF growth 5Y5.01%